Charcotrace™ studies and publications

For more information about Charcotrace, please call Pharmalab on (toll free) 1800 720 020.

1. Rose, A et al. Carbon localization of impalpable breast lesions. The Breast. Vol. 12, 2003: 264-269.

2. Moss, H. A. et al. The use of carbon suspension as an adjunct to wire localisation of impalpable breast lesions. Clinical Radiology. Vol. 57, 2002: 937-944.

3. Mullen, David J et al. The use of carbon marking after stereotactic large-core needle breast biopsy. Radiology. Vol. 218, No. 1, January 2001: 255-260.

4. Arman, A et al. Marking of nonpalapable breast lesions using a custom carbon suspension. Acta Radiologica. Vol. 42, 2001: 599-601.

5. Bonhomme-Faivre, L et al. Charcoal suspension for tumor labelling modifies macrophage activity in mice. Life Sciences. Vol, 66, No. 9, 2000: 817-827.

6. Yokota, T et al. Lymph-node staining with activated carbon CH-40: A new method for axillary lymph-node dissection in breast cancer. CJS. Vol. 43, No. 3, June 2000: 191-196.

7. Bonhomme-Faivre, L et al. Formulation of a charcoal suspension for intratumoral injection. Study of galenical excipients. Drug Development and Industrial Pharmacy. Vol. 25, No. 2, 1999: 175-186.

8. Patrikeos, A et al. Imaging of carbon granulomas of the breast following carbon track localization. Clinical Radiology. Vol. 53, 1998: 845-848.

9. Canavese, G et al. Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension. European Journal of Surgical Oncology. Vol 21, 1995: 47-49.

10. Langlois, S. Le P and Carter, M.L. Carbon localisation of impalpable mammographic abnormalities. Australasian Radiology. Vol. 35, No. 3, August 1991: 237-241.

11. Svane, G. A stereotaxic technique for pre-operative marking of non-palpable breast lesions. Acta Radiologica Diagnosis. Vol. 24, Fasc. 2, 1983: 145-151.